Immunology & Rheumatology Clinical Trials

Statistical methods in immunology & rheumatology trials

The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.

All immunology & rheumatology trials

727 results

• A Phase II Trial of Combined Weekly Bortezomib and Tositumomab I-131 in Patients With Relapsed or Refractory Follicular Non-Hodgkin’s Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of A Phase II Trial of Combined Weekly Bortezomib and Tositumomab I-131 in Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma: primary endpoint results, effect estimate with confidence interval,…Phase 2Results postedn = 1NCT00479167
• A Pilot and Feasibility Study of Mobile-Based Asthma Action Plans: Complete Statistical AnalysisIndependent statistical analysis of A Pilot and Feasibility Study of Mobile-Based Asthma Action Plans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01514760).Phase NAResults postedn = 22NCT01514760
• A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus.: Complete Statistical AnalysisIndependent statistical analysis of A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02185040).Phase 2Results postedn = 42NCT02185040
• A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL: Complete Statistical AnalysisIndependent statistical analysis of A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 1/2Results postedn = 23NCT01483690
• A Pilot Study of the Therapeutic Potential of Stem Cell Educator Therapy in Type 1 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of A Pilot Study of the Therapeutic Potential of Stem Cell Educator Therapy in Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 1Results postedn = 13NCT02624804
• A Placebo Controlled Trial of Dalfampridine ER for Ambulatory Activity in People With Multiple Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of A Placebo Controlled Trial of Dalfampridine ER for Ambulatory Activity in People With Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 4Results postedn = 43NCT01356940
• A Positive Psychology Intervention for Patients With Multiple Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of A Positive Psychology Intervention for Patients With Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03637699).Phase NAResults postedn = 30NCT03637699
• A Post Marketing Surveillance Study Assessing the Long-term Efficacy and Safety of Aptivus Co-administered With Low-dose Ritonavir in Treatment Experienced Patients With HIV-1 Infection in the Daily Clinical Practice.: Complete Statistical AnalysisIndependent statistical analysis of A Post Marketing Surveillance Study Assessing the Long-term Efficacy and Safety of Aptivus Co-administered With Low-dose Ritonavir in Treatment Experienced Patients With HIV-1 Infection in the Daily Clinical…Phase NAResults postedn = 42NCT00976950
• A Proof of Concept Pilot Trial of Alpha-1-Antitrypsin for Pre-Emption Of Steroid-Refractory Acute GVHD: Complete Statistical AnalysisIndependent statistical analysis of A Proof of Concept Pilot Trial of Alpha-1-Antitrypsin for Pre-Emption Of Steroid-Refractory Acute GVHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 2Results postedn = 30NCT03459040
• A Proof-of-Concept Study to Assess Batoclimab in Participants With Graves’ Disease: Complete Statistical AnalysisIndependent statistical analysis of A Proof-of-Concept Study to Assess Batoclimab in Participants With Graves' Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 2Results postedn = 32NCT05907668
• A Proof-of-concept Study to Evaluate the Efficacy and Safety of Rozanolixizumab to Treat Adult Study Participants With Severe Fibromyalgia Syndrome: Complete Statistical AnalysisIndependent statistical analysis of A Proof-of-concept Study to Evaluate the Efficacy and Safety of Rozanolixizumab to Treat Adult Study Participants With Severe Fibromyalgia Syndrome: primary endpoint results, effect estimate with confidence interval,…Phase 2Results postedn = 63NCT05643794
• A Prospective, Epidemiological Study to Assess the Disease Burden of Respiratory Syncytial Virus Associated, Suspected Lower Respiratory Tract Infections in Newborns, From 0 to 2 Years of Age and Risk of Development of Wheeze and Asthma From 0 to 6 Years of Age: Complete Statistical AnalysisIndependent statistical analysis of A Prospective, Epidemiological Study to Assess the Disease Burden of Respiratory Syncytial Virus Associated, Suspected Lower Respiratory Tract Infections in Newborns, From 0 to 2 Years of Age…Phase NAResults postedn = 2,409NCT01995175
• A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan: Complete Statistical AnalysisIndependent statistical analysis of A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 3Results postedn = 71NCT06240741
• A Prospective, Randomized, Double-blind, Placebo Controlled Study to Assess the Impact of ORMD-0801 (Insulin Capsules) on the Exogenous Insulin Requirements of Type 1 Diabetics: Complete Statistical AnalysisIndependent statistical analysis of A Prospective, Randomized, Double-blind, Placebo Controlled Study to Assess the Impact of ORMD-0801 (Insulin Capsules) on the Exogenous Insulin Requirements of Type 1 Diabetics: primary endpoint results, effect…Phase 2Results postedn = 25NCT02094534
• A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study): Complete Statistical AnalysisIndependent statistical analysis of A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 3Results postedn = 143NCT01892345
• A Randomized Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prurigo Nodularis (PN): Complete Statistical AnalysisIndependent statistical analysis of A Randomized Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prurigo Nodularis (PN): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 2Results postedn = 128NCT02196324
• A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Non-steroidal Therapy.: Complete Statistical AnalysisIndependent statistical analysis of A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Non-steroidal Therapy.: primary endpoint results, effect…Phase 2Results postedn = 599NCT00603382
• A Randomized Trial of Two Formal Group Programs for Multiple Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of A Randomized Trial of Two Formal Group Programs for Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 282NCT01918800
• A Randomized, Double-Blind, Placebo-Controlled Study of Oral Milk Immunotherapy for Cow’s Milk Allergy: Complete Statistical AnalysisIndependent statistical analysis of A Randomized, Double-Blind, Placebo-Controlled Study of Oral Milk Immunotherapy for Cow's Milk Allergy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 1/2Results postedn = 20NCT00465569
• A Retrospective, Open-label, Uncontrolled Cohort Study to Assess the Effectiveness and Safety of Lactulose Retention Enema in the Treatment of Cirrhotic Patients With Grade 3 or 4 (West Haven Criteria) Hepatic Encephalopathy (HE) [The RETRO Study]: Complete Statistical AnalysisIndependent statistical analysis of A Retrospective, Open-label, Uncontrolled Cohort Study to Assess the Effectiveness and Safety of Lactulose Retention Enema in the Treatment of Cirrhotic Patients With Grade 3 or 4 (West…Phase NAResults postedn = 50NCT02377947
• A Safety and Activity Study of NS2 in Subjects With Allergic Conjunctivitis: Complete Statistical AnalysisIndependent statistical analysis of A Safety and Activity Study of NS2 in Subjects With Allergic Conjunctivitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2Results postedn = 100NCT02578914
• A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma: Complete Statistical AnalysisIndependent statistical analysis of A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma: primary endpoint results,…Phase 3Results postedn = 1,113NCT02031640
• A Safety and Efficacy Study of CC-90011 in Participants With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin’s Lymphomas: Complete Statistical AnalysisIndependent statistical analysis of A Safety and Efficacy Study of CC-90011 in Participants With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase 1Results postedn = 75NCT02875223
• A Safety and Efficacy Study of Tralokinumab in Adults With Asthma: Complete Statistical AnalysisIndependent statistical analysis of A Safety and Efficacy Study of Tralokinumab in Adults With Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 2Results postedn = 689NCT01402986
• A Safety and Efficacy Study of Xyrem® in Subjects With Fibromyalgia: Complete Statistical AnalysisIndependent statistical analysis of A Safety and Efficacy Study of Xyrem® in Subjects With Fibromyalgia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 3Results postedn = 548NCT00371137
• A Safety Study of GSK3039294 in Healthy Volunteers and Patients With Systemic Amyloidosis: Complete Statistical AnalysisIndependent statistical analysis of A Safety Study of GSK3039294 in Healthy Volunteers and Patients With Systemic Amyloidosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 1Results postedn = 23NCT02603172
• A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma: Complete Statistical AnalysisIndependent statistical analysis of A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 3Results postedn = 197NCT00809757
• A Safety, Tolerability, Pharmacokinetics (PK) and Target Engagement (TE) Study of GSK3858279 in Healthy Participants and Evaluation of the Efficacy of Repeat Doses in Participants With Osteoarthritis (OA): Complete Statistical AnalysisIndependent statistical analysis of A Safety, Tolerability, Pharmacokinetics (PK) and Target Engagement (TE) Study of GSK3858279 in Healthy Participants and Evaluation of the Efficacy of Repeat Doses in Participants With Osteoarthritis (OA):…Phase 1Results postedn = 97NCT03485365
• A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment Into Clinical Research Studies of Zelboraf (Vemurafenib): Complete Statistical AnalysisIndependent statistical analysis of A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment Into Clinical Research Studies of Zelboraf (Vemurafenib): primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase NAResults postedn = 662NCT01804140
• A Severity-Adapted Clinical Trial of Diminished Bone Mineral Density in Acute Lymphoblastic Leukemia Survivors: Complete Statistical AnalysisIndependent statistical analysis of A Severity-Adapted Clinical Trial of Diminished Bone Mineral Density in Acute Lymphoblastic Leukemia Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 3Results postedn = 429NCT00186901
• A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases: Complete Statistical AnalysisIndependent statistical analysis of A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases: primary endpoint results, effect estimate with confidence interval, sample-size…Phase 2/3Results postedn = 65NCT05755035
• A Study Assessing the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis (SARIL-RA-HARUKA): Complete Statistical AnalysisIndependent statistical analysis of A Study Assessing the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis (SARIL-RA-HARUKA): primary endpoint results, effect…Phase 3Results postedn = 91NCT02373202
• A Study Comparing 2 Doses Of CP-690,550 Vs. Placebo For The Treatment Of Rheumatoid Arthritis In Patients On Other Background Arthritis Medications: Complete Statistical AnalysisIndependent statistical analysis of A Study Comparing 2 Doses Of CP-690,550 Vs. Placebo For The Treatment Of Rheumatoid Arthritis In Patients On Other Background Arthritis Medications: primary endpoint results, effect estimate with…Phase 3Results postedn = 795NCT00856544
• A Study Comparing Obinutuzumab (RO5072759; GA101) 1000 Milligram (mg) Versus 2000 mg in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL) (GAGE): Complete Statistical AnalysisIndependent statistical analysis of A Study Comparing Obinutuzumab (RO5072759; GA101) 1000 Milligram (mg) Versus 2000 mg in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL) (GAGE): primary endpoint results, effect estimate with…Phase 2Results postedn = 80NCT01414205
• A Study Comparing SB5 to Humira® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy: Complete Statistical AnalysisIndependent statistical analysis of A Study Comparing SB5 to Humira® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 3Results postedn = 544NCT02167139
• A Study Comparing Two Fluticasone Furoate Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis: Complete Statistical AnalysisIndependent statistical analysis of A Study Comparing Two Fluticasone Furoate Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis: primary endpoint results, effect estimate with confidence interval,…Phase 3Results postedn = 727NCT01279057
• A Study Designed to Compare the Tolerability of an Increased Dose of Enteric-coated Mycophenolate Acid (MPA) in Renal Transplant Patients Whose Dose of Mycophenolate Mofetil (MMF) Was Reduced Due to Gastrointestinal Symptoms: Complete Statistical AnalysisIndependent statistical analysis of A Study Designed to Compare the Tolerability of an Increased Dose of Enteric-coated Mycophenolate Acid (MPA) in Renal Transplant Patients Whose Dose of Mycophenolate Mofetil (MMF) Was Reduced…Phase 4Results postedn = 30NCT00658333
• A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®) in Patients Receiving High-Dose Melphalan Conditioning Followed by Autologous Stem Cell Transplantation for Multiple Myeloma and Non-Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®) in Patients Receiving High-Dose Melphalan Conditioning Followed by Autologous Stem Cell Transplantation for Multiple Myeloma and Non-Hodgkin Lymphoma: primary…Phase NAResults postedn = 114NCT02919670
• A Study Evaluating Desvenlafaxine Sustained Release (DVS SR) in Adult Female Outpatients With Fibromyalgia: Complete Statistical AnalysisIndependent statistical analysis of A Study Evaluating Desvenlafaxine Sustained Release (DVS SR) in Adult Female Outpatients With Fibromyalgia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 2Results postedn = 125NCT00696787
• A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis: Complete Statistical AnalysisIndependent statistical analysis of A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis: primary endpoint results, effect estimate with confidence interval,…Phase 4Results postedn = 580NCT00653224
• A Study Evaluating the Efficacy of Obinutuzumab and Bendamustine Treatment in Participants With Refractory or Relapsed Chronic Lymphocytic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of A Study Evaluating the Efficacy of Obinutuzumab and Bendamustine Treatment in Participants With Refractory or Relapsed Chronic Lymphocytic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size…Phase 2Results postedn = 72NCT02071225
• A Study Evaluating the Safety and Efficacy of Glofitamab or Mosunetuzumab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and High-Grade Large B-Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of A Study Evaluating the Safety and Efficacy of Glofitamab or Mosunetuzumab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and…Phase 1Results postedn = 23NCT04313608
• A Study Evaluating the Safety and Efficacy of SM04690 for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis: Complete Statistical AnalysisIndependent statistical analysis of A Study Evaluating the Safety and Efficacy of SM04690 for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size…Phase 2Results postedn = 700NCT03122860
• A Study for Patients With Non-Hodgkin’s Lymphomas: Complete Statistical AnalysisIndependent statistical analysis of A Study for Patients With Non-Hodgkin's Lymphomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00542919).Phase 2Results postedn = 57NCT00542919
• A Study in Adults With Untreated Acute Lymphoblastic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of A Study in Adults With Untreated Acute Lymphoblastic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00136435).Phase 2Results postedn = 100NCT00136435
• A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based: Complete Statistical AnalysisIndependent statistical analysis of A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 3Results postedn = 446NCT01820572
• A Study in Participants With Diabetic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of A Study in Participants With Diabetic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01113801).Phase 2Results postedn = 417NCT01113801
• A Study in Patients With Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of A Study in Patients With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00966875).Phase 2Results postedn = 448NCT00966875
• A Study Investigating the Effect of Montelukast in Patients With Seasonal Allergic Rhinitis (MK-0476-192)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of A Study Investigating the Effect of Montelukast in Patients With Seasonal Allergic Rhinitis (MK-0476-192)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 3Results postedn = 829NCT00960141
• A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects: Complete Statistical AnalysisIndependent statistical analysis of A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 3Results postedn = 211NCT00363142

← All therapeutic areas